Results 161 to 170 of about 1,875,746 (274)
The Impact of Two Data-Generating Processes for Competing Risk Data on the Discrimination and Calibration of Two Types of Competing Risk Regression Models. [PDF]
Austin PC, Putter H.
europepmc +1 more source
NKCC1: A key regulator of glioblastoma progression
Glioblastoma (GBM) progression is driven by disrupted chloride cotransporter homeostasis. NKCC1 is highly expressed in stem‐like, astrocytic, and progenitor cells, correlating with earlier recurrence, while overall survival remains unaffected. NKCC1 serves as a prognostic marker and potential therapeutic target, linking chloride transporter imbalance ...
Anja Thomsen +5 more
wiley +1 more source
Preface: ICFM9 – River Basin Disaster Resilience and Sustainability by All [PDF]
T. Koike +10 more
doaj +1 more source
Insomnia, sleep duration and incident Parkinson's disease in the Finnish population cohort. [PDF]
Sulkava S +3 more
europepmc +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
The tip of the iceberg: Profiling cooling agents using computational approaches to inform tobacco regulatory science. [PDF]
Chakraborty S +4 more
europepmc +1 more source
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak +10 more
wiley +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Correction: The Burr distribution as a model for the delay between key events in an individual's infection history. [PDF]
Jamieson N +3 more
europepmc +1 more source

